Mechanisms of synergistic skin penetration by sonophoresis and iontophoresis

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 5, 2009, Pages 905-909

  Hikima, Tomohiro ^a   Ohsumi, Shinya ^a   Shirouzu, Kenta ^a   Tojo, Kakuji ^a  

^a KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Electric charge; Iontophoresis; Molecular weight; Transdermal therapeutic system; Ultrasound

Indexed keywords

BENZOIC ACID; CYANOCOBALAMIN; HYDROCORTISONE; INDOMETACIN; LIDOCAINE; TIMOLOL MALEATE; VANCOMYCIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; ELECTRIC FIELD; ELECTRICITY; ELECTROOSMOSIS; FEMALE; IN VITRO STUDY; IONIZATION; IONTOPHORESIS; MATHEMATICAL MODEL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; SKIN PENETRATION; SKIN SURFACE; STRATUM CORNEUM; ULTRASOUND;

ADMINISTRATION, CUTANEOUS; ANIMALS; FEMALE; IONTOPHORESIS; MICE; MICE, HAIRLESS; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; PHONOPHORESIS; SKIN; SKIN ABSORPTION; SONICATION;

EID: 66749121267     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.905     Document Type: Article

References (19)

1. Prausnitz M. R., Mitragotri S., Langer R., Nat. Rev. Drug Discov., 3, 115-124 (2004).
2. Thong H.-Y., Zhai H., Maibach H. I., Skin Pharmacol. Physiol., 20, 272-282 (2007).
3. Williams A. C., Barry B. W., Adv. Drug Deliv. Rev., 56, 603-618 (2004).
4. Mitragotri S., Pharm. Res., 17, 1354-1359 (2000).
5. Nolan L. M. A., Corish J., Corrigan O. I., Fitzpatrick D., Int. J. Pharm., 341, 114-124 (2007).
6. Fang J.-Y., Lee W.-R., Shen S.-C., Fang Y.-P., Hu C.-H., Br. J. Dermatol., 151, 132-140 (2004).
7. Shirouzu K., Nishiyama T., Hikima T., Tojo K., J. Chem. Eng. Jpn., 42, 300-305 (2008).
8. Tojo K., "Mathematical Models of Transdermal and Topical Drug Delivery," 2nd ed., Biocom Systems Inc., Fukuoka, 2005.
9. Brown M. B., Martin G. P., Jones S. A., Akomeah F. K., Drug Deliv., 13, 175-187 (2006).
10. Miyagi T., Hikima T., Tojo K., J. Chem. Eng. Jpn., 39, 360-365
11. (2006).
12. Hikima T., Hirai Y., Tojo K., Pharm. Res., 15, 1680-1683 (1998).
13. Hikima T., Maibach H. I., Biol. Pharm. Bull., 29, 2270-2273 (2006).
14. Noble W. C., "Medical Importance of the Normal Microflora," Chap. 2, ed. by Tannock G. W., Kluwer Academic, Dordrecht, 1999, pp. 24-46.
15. Wearley L. L., "Factors Affecting Reversibility of Iontophoretic Transdermal Transport," Ph.D. Thesis, Rutgers University, New Brunswick, NJ, 1989.
16. Pikal M. J., Adv. Drug Deliv., 46, 281-305 (2001).
17. Boucaud A., Garrigue M. A., Machet L., Vaillant L., Patat F., J. Controlled Release, 81, 113-119 (2002).
18. Pikal M. J., Shah S., Pharm. Res., 7, 222-229 (1990).
19. Peck K. D., Srinivasan V., Li S. K., Higuchi W. I., Ghanem A.-H., J. Pharm. Sci., 85, 781-788 (1996).